If I had a promising new drug, I'd want someone with years of experience in getting a drug approved helping me out and the billions in capital to get it done wouldn't hurt either (which of course is available because Novartis sold a number of profitable drugs).

The professor who came up with this science is going to get a cut of that, as will the university.